Concepedia

Chi Meng

CM

Statistics

Publications

18

Citations

459

H-Index

14

Active since

2019

Affiliations

Nantong University(Current)

Affiliated Hospital of Nantong University

Macau University of Science and Technology

Wuxi Third People's Hospital

Chi Meng is an author at Nantong University specializing in oncology, pharmacology, and medicine.

ORCID

Publications per year

2019–2023

18

Publications

18

Excellent antitumor and antimetastatic activities based on novel coumarin/pyrazole oxime hybrids

Hong Dai, Meiling Huang, Jianqiang Qian et al. · European Journal of Medicinal Chemistry · 2019 · 60 citations

, , +9

β-Carboline and N-hydroxycinnamamide hybrids as anticancer agents for drug-resistant hepatocellular carcinoma

Yong Ling, Weijie Gao, Chang‐Chun Ling et al. · European Journal of Medicinal Chemistry · 2019 · 44 citations · Full text

, , +12

Piperlonguminine and Piperine Analogues as TrxR Inhibitors that Promote ROS and Autophagy and Regulate p38 and Akt/mTOR Signaling

Peng Zhu, Jianqiang Qian, Zhongyuan Xu et al. · Journal of Natural Products · 2020 · 44 citations · Full text

, , +15

Hydroxamic Acid Derivatives of β-Carboline/Hydroxycinnamic Acid Hybrids Inducing Apoptosis and Autophagy through the PI3K/Akt/mTOR Pathways

Yong Ling, Yangyang Li, Rui Zhu et al. · Journal of Natural Products · 2019 · 42 citations · Full text

, , +15

Design and synthesis of benzylidenecyclohexenones as TrxR inhibitors displaying high anticancer activity and inducing ROS, apoptosis, and autophagy

Jianqiang Qian, Zhongyuan Xu, Chi Meng et al. · European Journal of Medicinal Chemistry · 2020 · 36 citations

, , +10

1–5 of 18